Tower Research Capital (TRC)’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30K	Buy	7,992 +3,997	+100%	+$15.8K	﹤0.01%	3166
2025 Q4	$14.1K	Sell	3,995 -1,614	-29%	-$6.55K	﹤0.01%	3368
2025 Q3	$22.4K	Sell	5,609 -7,170	-56%	-$22.6K	﹤0.01%	3213
2025 Q2	$34.2K	Buy	12,779 +2,645	+26%	+$5.56K	﹤0.01%	3302
2025 Q1	$14.3K	Buy	10,134 +4,537	+81%	+$7.71K	﹤0.01%	3304
2024 Q4	$11.1K	Buy	5,597 +951	+20%	+$2.49K	﹤0.01%	3746
2024 Q3	$14.6K	Buy	+4,646	New	+$14.7K	﹤0.01%	3448
2024 Q1	–	Sell	-14,641	Closed	-$24.3K	–	5830
2023 Q4	$24.3K	Buy	14,641 +10,521	+255%	+$9.71K	﹤0.01%	3536
2023 Q3	$3.7K	Sell	4,120 -1,601	-28%	-$2.13K	﹤0.01%	4969
2023 Q2	$12.3K	Buy	5,721 +5,658	+8,981%	+$12.7K	﹤0.01%	3887
2023 Q1	$0	Sell	63 -2,872	-98%	-$10.6K	﹤0.01%	5752
2022 Q4	$11K	Sell	2,935 -6,538	-69%	-$26.1K	﹤0.01%	3785
2022 Q3	$46K	Buy	9,473 +8,773	+1,253%	+$63.5K	﹤0.01%	3227
2022 Q2	$6K	Sell	700 -37	-5%	-$350	﹤0.01%	4887
2022 Q1	$10K	Sell	737 -1,452	-66%	-$23K	﹤0.01%	4268
2021 Q4	$44K	Buy	2,189 +2,144	+4,764%	+$51.7K	﹤0.01%	2853
2021 Q3	$1K	Buy	+45	New	+$1.15K	﹤0.01%	5416
2021 Q2	–	Sell	-82	Closed	-$2K	–	5425
2021 Q1	$2K	Sell	82 -4,521	-98%	-$131K	﹤0.01%	4993
2020 Q4	$147K	Buy	+4,603	New	+$151K	﹤0.01%	1998